Showing results (111-120 of 3,787) with videos related to

Sort By:
Pageof 379
Oncoimmunology|May 13, 2020
CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancerKatsuhiro Yoshimura, Yuzo Suzuki, Yusuke Inoue, et al.
Oncoimmunology|September 13, 2021
In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpartFrancis Man, Alexander Koers, Panagiotis Karagiannis, et al.
Oncoimmunology|September 16, 2021
Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinomaWeiju Zhang, Sumei Yao, Hua Huang, et al.
Oncoimmunology|September 16, 2021
Monoacylglycerol lipase deficiency in the tumor microenvironment slows tumor growth in non-small cell lung cancerMelanie Kienzl, Carina Hasenoehrl, Kathrin Maitz, et al.
Oncoimmunology|September 16, 2021
Stromal infiltrating mast cells identify immunoevasive subtype high-grade serous ovarian cancer with poor prognosis and inferior immunotherapeutic responseKankan Cao, Guodong Zhang, Xiangyun Zhang, et al.
Oncoimmunology|May 6, 2015
Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cellsSarah K Maenhout, Kris Thielemans, Joeri L Aerts
Oncoimmunology|May 6, 2015
Overcoming immunosuppression to enhance a p53MVA vaccineNicola Hardwick, Vincent Chung, Mihaela Cristea, et al.
Oncoimmunology|May 6, 2015
Chemokine and lymph node homing receptor expression on pDC vary by graft sourceSakura Hosoba, Wayne Ac Harris, Kaifeng L Lin, et al.
Oncoimmunology|May 6, 2015
Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapyEric R Lutz, Heather Kinkead, Elizabeth M Jaffee, et al.
Oncoimmunology|May 6, 2015
Trial watch: Dendritic cell-based anticancer therapyNorma Bloy, Jonathan Pol, Fernando Aranda, et al.
Pageof 379